Deshan Li

784 total citations
29 papers, 576 citations indexed

About

Deshan Li is a scholar working on Genetics, Animal Science and Zoology and Immunology. According to data from OpenAlex, Deshan Li has authored 29 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 10 papers in Animal Science and Zoology and 10 papers in Immunology. Recurrent topics in Deshan Li's work include Virus-based gene therapy research (15 papers), Animal Virus Infections Studies (10 papers) and Molecular Sensors and Ion Detection (5 papers). Deshan Li is often cited by papers focused on Virus-based gene therapy research (15 papers), Animal Virus Infections Studies (10 papers) and Molecular Sensors and Ion Detection (5 papers). Deshan Li collaborates with scholars based in China, United States and Australia. Deshan Li's co-authors include Guiping Ren, Fuliang Bai, Jiechao Yin, Qingzhong Yu, Zhibin Wang, Lin‐Hai Han, Zhong Tao, Yin-Hang Yu, Hui Tian and Yunzhou Wu and has published in prestigious journals such as PLoS ONE, Macromolecules and Chemical Communications.

In The Last Decade

Deshan Li

28 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deshan Li China 14 282 181 145 110 96 29 576
Binbin Xue China 16 29 0.1× 476 2.6× 41 0.3× 333 3.0× 28 0.3× 31 873
Erkko Ylösmäki Finland 18 391 1.4× 514 2.8× 353 2.4× 260 2.4× 56 0.6× 27 1.0k
Songping Wang United States 14 59 0.2× 214 1.2× 53 0.4× 31 0.3× 104 1.1× 28 577
Justin B. Robbins United States 16 141 0.5× 411 2.3× 88 0.6× 75 0.7× 26 0.3× 17 1.3k
Jiajie Wei United States 15 40 0.1× 281 1.6× 55 0.4× 92 0.8× 22 0.2× 25 539
Qiaoyun Zhu China 15 59 0.2× 381 2.1× 59 0.4× 110 1.0× 5 0.1× 36 666
Zining Wang China 14 60 0.2× 449 2.5× 185 1.3× 408 3.7× 19 0.2× 36 814
Junsong Zhang China 15 42 0.1× 288 1.6× 63 0.4× 169 1.5× 24 0.3× 40 609
Jung Hoon Ahn South Korea 15 136 0.5× 337 1.9× 75 0.5× 83 0.8× 3 0.0× 25 586
Joanne McCaffrey United Kingdom 14 134 0.5× 503 2.8× 64 0.4× 286 2.6× 33 0.3× 21 923

Countries citing papers authored by Deshan Li

Since Specialization
Citations

This map shows the geographic impact of Deshan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deshan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deshan Li more than expected).

Fields of papers citing papers by Deshan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deshan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deshan Li. The network helps show where Deshan Li may publish in the future.

Co-authorship network of co-authors of Deshan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Deshan Li. A scholar is included among the top collaborators of Deshan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deshan Li. Deshan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Liying, Yuanyuan Yan, Chenxi Hu, et al.. (2025). A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice model. Journal of Translational Medicine. 23(1). 1056–1056.
2.
3.
Li, Haihong, et al.. (2022). An investigation on the mechanisms of ant nest corrosion of copper tube in formic acid environment. Materials and Corrosion. 74(1). 138–144. 3 indexed citations
4.
Su, Han, Tianyan Liu, Yu Zhang, et al.. (2022). Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model. PLoS ONE. 17(4). e0264896–e0264896. 5 indexed citations
5.
Yin, Qi, Yuanyuan Jiang, Guiping Ren, et al.. (2021). An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice. Inflammation. 44(5). 1724–1736. 45 indexed citations
6.
Su, Han, et al.. (2021). Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy. Gene Therapy. 30(1-2). 64–74. 17 indexed citations
7.
Dong, Na, Xinyao Xu, Chenyu Xue, et al.. (2019). Ethyl pyruvate protects against Salmonella intestinal infection in mice through down-regulation of pro-inflammatory factors and inhibition of TLR4/MAPK pathway. International Immunopharmacology. 71. 155–163. 25 indexed citations
8.
Wu, Yunzhou, Jinjiao He, Jingshu Geng, et al.. (2017). Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy. European Journal of Pharmacology. 802. 85–92. 25 indexed citations
9.
Wu, Yunzhou, Jinjiao He, Ying An, et al.. (2016). Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy. Journal of Pharmacological Sciences. 132(1). 24–30. 33 indexed citations
10.
He, Jinjiao, Yunye Liu, Jiarui Yang, et al.. (2016). Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect. PLoS ONE. 11(10). e0164723–e0164723. 10 indexed citations
11.
An, Ying, Jinjiao He, Rui Chen, et al.. (2016). Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model. Journal of Biomedical Science. 23(1). 55–55. 18 indexed citations
12.
Wang, Zhibin, Zhong Tao, Deshan Li, & Lin‐Hai Han. (2016). Cyclic behaviour of novel blind bolted joints with different stiffening elements. Thin-Walled Structures. 101. 157–168. 60 indexed citations
13.
Ren, Guiping, Guiyou Tian, Yunye Liu, et al.. (2015). Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy. Technology in Cancer Research & Treatment. 15(5). NP83–NP94. 25 indexed citations
14.
Bai, Fuliang, Yin-Hang Yu, Hui Tian, et al.. (2014). Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy. Cancer Biology & Therapy. 15(9). 1226–1238. 74 indexed citations
15.
Bai, Fuliang, Hui Tian, Siming Li, et al.. (2014). Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy. Immunology Letters. 159(1-2). 36–46. 34 indexed citations
16.
Li, Siming, Fuliang Bai, Wenjuan Xu, et al.. (2014). Removing residual DNA from Vero-cell culture-derived human rabies vaccine by using nuclease. Biologicals. 42(5). 271–276. 11 indexed citations
17.
Sun, Tian, Guiyou Tian, Fuliang Bai, et al.. (2014). [The synergism and mechanism of action of rClone30-hDR5 in combination with TRAIL on HCC].. PubMed. 49(7). 985–92. 2 indexed citations
18.
Bai, Fuliang, Hui Tian, Mingyao Liu, et al.. (2013). Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis. International Journal of Molecular Medicine. 33(3). 711–721. 14 indexed citations
19.
Wu, Yunzhou, Shijun Yan, Zheng Lv, et al.. (2013). Recombinant Newcastle Disease Virus Anhinga Strain (NDV/Anh-EGFP) for Hepatoma Therapy. Technology in Cancer Research & Treatment. 13(2). 169–175. 9 indexed citations
20.
Zhang, Yu, Guiping Ren, Jingzhuang Zhao, et al.. (2012). Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model. International Immunopharmacology. 15(2). 199–205. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Binbin Xue Breakdown of academic impact, for papers by Erkko Ylösmäki Breakdown of academic impact, for papers by Songping Wang Breakdown of academic impact, for papers by Justin B. Robbins Breakdown of academic impact, for papers by Jiajie Wei Breakdown of academic impact, for papers by Qiaoyun Zhu Breakdown of academic impact, for papers by Zining Wang Breakdown of academic impact, for papers by Junsong Zhang Breakdown of academic impact, for papers by Jung Hoon Ahn Breakdown of academic impact, for papers by Joanne McCaffrey
Rankless by CCL
2026